Aristides Chaconas, MD
Neurology · Charlotte, NCNPI 1710954359
Payments from drug & device makers
Across 92 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- MDD US Operations, LLC$762
- Sunovion Pharmaceuticals Inc.$139
- Lilly USA, LLC$101
- Merz Pharmaceuticals, LLC$81
- Amneal Pharmaceuticals LLC$81
- Acorda Therapeutics, Inc$58
- plus $220 from 8 others
What the payments were for
- Speaking & faculty fees$876%
- Food & beverage$1,35694%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| MDD US Operations, LLC | 59 | $762 |
| Sunovion Pharmaceuticals Inc. | 8 | $139 |
| Lilly USA, LLC | 6 | $101 |
| Merz Pharmaceuticals, LLC | 3 | $81 |
| Amneal Pharmaceuticals LLC | 3 | $81 |
| Acorda Therapeutics, Inc | 3 | $58 |
| GE HealthCare | 1 | $41 |
| AbbVie | 2 | $41 |
| Avanir Pharmaceuticals, Inc. | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Neurocrine Biosciences, Inc. | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GOCOVRI$273
How this compares
$1,442 in reported general payments places this provider in the 50th percentile of 566 neurology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NuplazidPimavanserin Tartrate | 21 | $115,383 |
| Memantine Hcl | 394 | $18,191 |
| Donepezil Hcl | 398 | $5,706 |
| Rivastigmine | 22 | $4,999 |
| Sertraline Hcl | 277 | $2,951 |
| Trazodone Hcl | 206 | $2,893 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 62 | $2,359 |
| Bupropion XlBupropion Hcl | 84 | $2,133 |
| Duloxetine Hcl | 59 | $1,880 |
| Escitalopram Oxalate | 127 | $1,613 |
| Memantine Hcl ErMemantine Hcl | 33 | $1,318 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 24 | $1,157 |
| Galantamine Hbr | 12 | $1,125 |
| Quetiapine Fumarate | 72 | $1,113 |
| RivastigmineRivastigmine Tartrate | 18 | $962 |
Paid to pharmacies, not to this prescriber.
Other neurology in Charlotte
- Mohammad BolouriCharlotte$16.6M
- T RaoCharlotte$4M
- Donna GravesCharlotte$1.8M
- Jill ConwayCharlotte$1.6M
- Matthew CarraroCharlotte$1.5M
- Urvi DesaiCharlotte$937K
- Ardith CourtneyCharlotte$862K
- Sanjay IyerCharlotte$685K
- Megan DonnellyCharlotte$601K
- Kenneth AshkinCharlotte$525K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.